Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)()

The Coronavirus disease (COVID-19) pandemic is disrupting our health environment. As expected, studies highlighted the great susceptibility of cancer patients to COVID-19 and more severe complications, leading oncologists to deeply rethink patient cancer care. This review is dedicated to the optimiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Slimano, Florian, Baudouin, Amandine, Zerbit, Jérémie, Toulemonde-Deldicque, Anne, Thomas-Schoemann, Audrey, Chevrier, Régine, Daouphars, Mikaël, Madelaine, Isabelle, Pourroy, Bertrand, Tournamille, Jean-François, Astier, Alain, Ranchon, Florence, Cazin, Jean-Louis, Bardin, Christophe, Rioufol, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308737/
https://www.ncbi.nlm.nih.gov/pubmed/32623296
http://dx.doi.org/10.1016/j.ctrv.2020.102063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308737/
https://www.ncbi.nlm.nih.gov/pubmed/32623296
http://dx.doi.org/10.1016/j.ctrv.2020.102063

Ejemplares similares